Publications by authors named "Yu Tzu Tai"

Claim this Profile
E
Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
Teru Hideshima, Klaus Podar, Dharminder Chauhan, Kenji Ishitsuka, Constantine Mitsiades, Yu-Tzu Tai

Oncogene· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.
Keiji Kurata, Mehmet K Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Yu-Tzu Tai

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, Teresa Calimeri, Jiang Meng, Yu-Tzu Tai

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Yan Song, Paul Richardson

Leukemia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, Teresa Calimeri, Jiang Meng, Yu-Tzu Tai

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA Damage.
Yu-Tzu Tai, Gerrard Teoh, Boris Lin, Faith E Davies, Dharminder Chauhan

J Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.
Subodh Kumar, Srikanth Talluri, Jiangning Zhao, Chengcheng Liao, Lakshmi B Potluri, Yu-Tzu Tai

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Cytokines Modulate Telomerase Activity in a Human Multiple Myeloma Cell Line.
Masaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, Yu-Tzu Tai, Constantine S Mitsiades

Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Effects of Oligonucleotide N3'→P5' Thio-phosphoramidate (GRN163) Targeting Telomerase RNA in Human Multiple Myeloma Cells.
Masaharu Akiyama, Teru Hideshima, Masood A Shammas, Toshiaki Hayashi, Makoto Hamasaki, Yu-Tzu Tai

Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling.
Yu-Tzu Tai, Klaus Podar, Laurence Catley, Yu-Hua Tseng, Masaharu Akiyama

Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Nuclear Factor-κB p65 Mediates Tumor Necrosis Factor α-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein.
Masaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, Yu-Tzu Tai, Constantine S Mitsiades

Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications.
Yu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, Renate Burger, Klaus Podar

Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yu-Tzu Tai

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.
Ola Rizq, Naoya Mimura, Motohiko Oshima, Shuji Momose, Naoya Takayama, Yu-Tzu Tai

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.
Ola Rizq, Naoya Mimura, Motohiko Oshima, Shuji Momose, Naoya Takayama, Yu-Tzu Tai

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.
Subodh Kumar, Jiangning Zhao, Srikanth Talluri, Leutz Buon, Shidai Mu, Yu-Tzu Tai

Gastroenterology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.
Ting Du, Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Yu-Tzu Tai

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.
Keiji Kurata, Mehmet K Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Yu-Tzu Tai

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Keiji Kurata, Anna James-Bott, Mark A Tye, Leona Yamamoto, Mehmet K Samur, Yu-Tzu Tai

Blood Cancer J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Eugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, Caroline F Ribeiro, Leon Wert-Lamas, Yu-Tzu Tai

Blood· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Keiji Kurata, Anna James-Bott, Mark A Tye, Leona Yamamoto, Mehmet K Samur, Yu-Tzu Tai

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies in multiple myeloma treatment: A journey in progress.
Shih-Feng Cho, Tsung-Jang Yeh, Kenneth C Anderson, Yu-Tzu Tai

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Yu-Tzu Tai

Blood Cancer J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Sophia Adamia, Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey G Fell, Yu-Tzu Tai, Anthony Letai

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, Robert Redd, Eileen M Boyle, Yu-Tzu Tai

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis